Document is current
Any future updates will be listed below
-
Authors
Liang, Lindsay
Fazel Darbandi, Siavash
Pochareddy, Sirisha
Gulden, Forrest O.
Gilson, Michael C.
Sheppard, Brooke K.
Sahagun, Atehsa
An, Joon-Yong
Werling, Donna M.
Rubenstein, John L. R.
Sestan, Nenad
Bender, Kevin J.
Sanders, Stephan J. https://orcid.org/0000-0001-9112-5148
-
Funding
Funding for this research was provided by:
Simons Foundation Autism Research Initiative (574598)
Simons Foundation Autism Research Initiative (647371)
Simons Foundation Autism Research Initiative (629287)
Simons Foundation Autism Research Initiative (513133)
National Institute of Mental Health (R01 MH111662)
National Institute of Mental Health (U01 MH122681)
National Institute of Mental Health (P50 MH106934)
National Institute of Mental Health (R01 MH109904)
National Institute of Mental Health (R01 MH110926)
National Institute of Mental Health (U01 MH116488)
National Institute of Mental Health (U01 MH122678)
National Institute of Neurological Disorders and Stroke (R01 NS099099)
National Research Foundation of Korea (NRF-2020R1C1C1003426)
National Research Foundation of Korea (NRF-2017M3C7A1026959)
- License Information
-
More Information
Article History
Received: 8 December 2020
Accepted: 5 August 2021
First Online: 23 August 2021
Declarations
:
: This study was conducted using de-identified human data therefore IRB review was not required. IRB procedures for the data generation have been described previously [ , , ]. For the mouse data, all procedures and animal care were approved by the UCSF Institutional Animal Care Use Committee (IACUC, AN180174-03) and performed in accordance with the University of California San Francisco Laboratory Animal Research Center (LARC) guidelines. The research performed conformed to the principles of the Helsinki Declaration.
: This study was conducted using de-identified human data available for general research use [ , , ].
: J.L.R.R. is cofounder, stockholder, and currently on the scientific board of <i>Neurona</i>, a company studying the potential therapeutic use of interneuron transplantation. S.J.S. receives research funding from <i>BioMarin Pharmaceutical Inc.</i> The remaining authors declare that they have no competing interests.
